OUR PROJECTS

The Roundtable on Sustainable Biofuels (RSB) is an international initiative coordinated by the Energy Centre at the École Polytechnique Fédérale de Lausanne (EPFL). It brings together farmers, companies, non-governmental organisations, experts, governments, and intergovernmental agencies concerned with ensuring the sustainability of biofuel production and processing.  In support of RSB, Kimetrica developed guidelines and tools for farmers, biofuel producers and environmental and social impact analysts to determine compliance with the RSB Principle on biofuel production impacts on local food security. The food security assessment tools were integrated into the Energy Centre’s guidelines for assessing biofuel impacts in all sectors. Future guidance may include web-based decision support and survey guidance, as well impact simulation modelling.

With the significant expansion of HIV/AIDS, TB and OVC programmes in Africa, there is both an urgent need to meet the demand for expanding programmes and, at the same time, address the increased food security and nutritional needs of programme clients.  Under a contract with UNAIDS, Kimetrica conducted a study on the feasibility and potential impact on smallholder incomes of market opportunities for supplying food to support antiretroviral therapy (ART) and Tuberculosis (TB) treatment programmes and Orphans and Vulnerable Children (OVC) services in Africa.  Kimetrica conducted case studies in six African countries to gain insight and practical knowledge of the potential benefits, costs, risks and constraints of investing in smallholder supply chains for donor-funded health and social protection programmes. In addition, Kimetrica's staff mapped potential partners in 20 African countries, ranging from NGOs to farmer groups to health facilities that can manage procurement of food between small farmers and social protection programmes.  The study’s findings were used to develop programmes to support smallholder production and to provide nutritional support to HIV/AIDS, TB and OVC beneficiaries.